Technical Analysis for SNY - Sanofi

Grade Last Price % Change Price Change
grade C 42.24 1.42% 0.59
SNY closed up 1.42 percent on Tuesday, January 15, 2019, on 78 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Flat Down Down
See historical SNY trend table...

Date Alert Name Type % Chg
Jan 15 Crossed Above 200 DMA Bullish 0.00%
Jan 15 Narrow Range Bar Range Contraction 0.00%
Jan 15 Gapped Up Strength 0.00%
Jan 14 Fell Below 200 DMA Bearish 1.42%
Jan 14 MACD Bearish Signal Line Cross Bearish 1.42%
Jan 14 Narrow Range Bar Range Contraction 1.42%
Jan 14 Gapped Down Weakness 1.42%
Jan 11 Narrow Range Bar Range Contraction -0.47%
Jan 10 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.38%
Jan 10 MACD Bullish Signal Line Cross Bullish -1.38%

Older signals for SNY ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Sanofi researches, develops, manufactures, and markets healthcare products worldwide. The company operates through Pharmaceuticals, Human Vaccines, and Animal Health segments. Its principal products include Lantus and Apidra analogs of human insulin; Insuman, a range of human insulin solutions and suspensions; Amaryl, an oral once-daily sulfonylurea; BGStar and iBGStar blood glucose meters; enzyme replacement therapies, such as Cerezyme for Gaucher disease, Fabrazyme for Fabry, and Myozyme/Lumizyme for Pompe disease; Aubagio, an oral immunomodulator for multiple sclerosis; Taxotere, a taxane derivative for various cancer types; Eloxatine for colorectal cancer; and Jevtana for prostate cancer. The company's products also consist of thrombosis medicines, such as Plavix anti-platelet agent for atherothrombotic conditions and Lovenox to prevent and treat deep vein thrombosis; and cardiovascular medicines include Multaq anti-arrhythmic agent and Aprovel/CoAprovel for hypertension treatments. It also offers Renagel/Renvela oral phosphate binders used in patients with chronic kidney disease on dialysis to treat high phosphorus levels; Synvisc and Synvisc-One viscosupplements to treat pain associated with osteoarthritis of certain joints; and pediatric and influenza, adult and adolescent booster, meningitis and pneumonia, and travel and endemics vaccines. In addition, the company provides pharmaceuticals and vaccines used by veterinarians, farmers, and pet owners; consumer health care products to treat fever, pain, and digestive health areas; and generic medicines. Sanofi distributes its products through its sales force, as well as through physicians, pharmacies, hospitals, distributors, veterinaries, chemists, and wholesalers. It has alliance arrangements with Bristol-Myers Squibb, Regeneron, and Warner Chilcott. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1970 and is headquartered in Paris, France.
Is SNY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 45.86
52 Week Low 37.43
Average Volume 1,124,453
200-Day Moving Average 42.0456
50-Day Moving Average 43.9656
20-Day Moving Average 42.8635
10-Day Moving Average 42.608
Average True Range 0.737
ADX 16.27
+DI 22.7438
-DI 34.1371
Chandelier Exit (Long, 3 ATRs ) 43.349
Chandelier Exit (Short, 3 ATRs ) 43.221
Upper Bollinger Band 44.3976
Lower Bollinger Band 41.3294
Percent B (%b) 0.3
BandWidth 7.158072
MACD Line -0.4865
MACD Signal Line -0.4563
MACD Histogram -0.0302
Fundamentals Value
Market Cap 106.08 Billion
Num Shares 2.51 Billion
EPS 4.31
Price-to-Earnings (P/E) Ratio 9.80
Price-to-Sales 2.74
Price-to-Book 1.72
PEG Ratio 1.86
Dividend 1.64
Dividend Yield 3.88%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.72
Resistance 3 (R3) 42.70 42.53 42.64
Resistance 2 (R2) 42.53 42.40 42.54 42.61
Resistance 1 (R1) 42.38 42.33 42.46 42.40 42.59
Pivot Point 42.21 42.21 42.24 42.22 42.21
Support 1 (S1) 42.06 42.08 42.14 42.08 41.89
Support 2 (S2) 41.89 42.01 41.90 41.87
Support 3 (S3) 41.74 41.89 41.84
Support 4 (S4) 41.76